Can Activation of Acetylcholinesterase by β-Amyloid Peptide Decrease the Effectiveness of Cholinesterase Inhibitors?

A central event in the pathogenesis of Alzheimer’s disease (AD) is the accumulation of senile plaques composed of aggregated amyloid-β (Aβ) peptides. The main class of drugs currently used for the treatment of AD are the acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitors. In thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zueva, Irina V., Vasilieva, Elmira A., Gaynanova, Gulnara A., Moiseenko, Andrey V., Burtseva, Anna D., Boyko, Konstantin M., Zakharova, Lucia Ya., Petrov, Konstantin A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671303/
https://www.ncbi.nlm.nih.gov/pubmed/38003588
http://dx.doi.org/10.3390/ijms242216395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671303/
https://www.ncbi.nlm.nih.gov/pubmed/38003588
http://dx.doi.org/10.3390/ijms242216395

Ejemplares similares